Phase 1 Bipolar Disorder I Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

SchizophreniaSchizo Affective DisorderBipolar Disorder I+2 more

BioXcel Therapeutics Inc140 enrolled5 locationsNCT05025605

Completed

Phase 1

Open-Label Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching from Oral Risperidone to Risperidone Implant (DLP-114)

SchizophreniaBipolar Disorder IAutistic Disorder

Delpor Australia Pty Ltd17 enrolled1 locationACTRN12617001251314